Cell Free DNA

New UW Medicine-BBI Study Identifies Association Between Severity of Preeclampsia and Cell-Free DNA

July 28, 2021 | by BBI Communications

A new scientific study led by Brotman Baty Institute members offers insights into pregnant women with preeclampsia and the association between the severity of the condition and high-circulating cell-free DNA.

Read More

Test reliably detects tumor mutations in blood of patients with advanced prostate cancer

June 10, 2019 | by By Michael McCarthy

Sequencing cell-free DNA found in blood plasma could provide patients with advanced disease an alternative to biopsy

Read More

BBI Cell-free DNA Working Group Assesses First Year of Progress

June 26, 2019 | by Michael McCathy, MD

The Brotman Baty Institute for Precision Medicine (BBI) launched its cell-free DNA (cfDNA) working group in 2018, awarding grants for more than a dozen pilot studies to apply a cfDNA assay developed and validated by BBI to address a wide variety of clinical challenges.

Read More

Blood cell mutations confound prostate cancer liquid biopsy

November 04, 2020 | by UW Medicine Newsroom

Unrelated mutations, when present in the blood, can lead to false positive results in men with advanced prostate cancer who are undergoing liquid biopsies. Such tests, which look for variants in the cell-free DNA that tumors shed into the blood plasma, help determine suitable treatment options.

Read More